Keyphrases
New-onset Refractory Status Epilepticus (NORSE)
38%
Pediatric
34%
Critically Ill children
32%
Cocaine
27%
Electroencephalography
26%
Acquired Brain Injury
23%
Seizure
23%
Confidence Interval
20%
Paediatric Neurology
19%
Continuous Electroencephalogram
18%
Quantitative Electroencephalography (qEEG)
18%
Adult Mice
18%
Neonate
17%
Pediatric Neurocritical Care
17%
Oscillation
16%
Nucleus Accumbens
16%
Benzodiazepines
16%
United States
15%
Survivors
13%
Child Neurology
12%
Electroencephalographic Monitoring
12%
Cocaine-induced
12%
Locomotor Sensitization
12%
Pediatric Critical Care
11%
Status Epilepticus
11%
Time-to-treatment
11%
Odds Ratio
11%
Pediatric Patients
11%
North America
11%
Electroencephalogram
11%
Functional Neurological Disorder
11%
Neonatal Encephalopathy
11%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
10%
Neurology Residency
9%
Canada
9%
Neurocritical Care
9%
Neuromonitoring
8%
Antiseizure Medication
8%
Traumatic Brain Injury
8%
Developmental Delay
8%
Concussion
8%
Non-benzodiazepine
7%
Hospital Discharge
7%
Lacosamide
7%
Hospital Admission
7%
Brain Injury
7%
Clinical Outcomes
7%
Prenatal Cocaine Exposure
7%
Young children
7%
Post-intensive Care Syndrome
7%
Medicine and Dentistry
Pediatrics
100%
Epileptic Seizure
46%
Status Epilepticus
41%
Intensive Care
33%
Pediatric Neurology
28%
Intensive Care Unit
26%
Acquired Brain Injury
22%
Pediatrics Patient
19%
Neurologic Disease
18%
Diseases
17%
Neonate
15%
Benzodiazepine
15%
Neuromonitoring
14%
Disease
13%
Brain Injury
13%
Spectroscopy
12%
Electroencephalography Monitoring
12%
Extracorporeal Membrane Oxygenation
12%
Toddlers
12%
Brain Disease
11%
Odds Ratio
11%
Time to Treatment
10%
Outpatient
9%
Magnetic Resonance Imaging
8%
Patient Population
8%
Patient Care
8%
Neurology
7%
Biological Marker
7%
Prognostication
7%
Emergency Care
7%
Diagnosis
7%
Heart Arrest
6%
Concussion
6%
Sleep Disorder
6%
Nonbenzodiazepine
6%
Quality of Life
6%
Sequela
6%
Developmental Delay
6%
Critical Illness
6%
Infantile Spasm
6%
Cohort Analysis
5%
Cross Sectional Study
5%
Retinal Haemorrhage
5%
Myelin Oligodendrocyte Glycoprotein
5%
Neonatal Intensive Care Unit
5%
Optic Neuritis
5%
Targeted Therapy
5%
Lacosamide
5%
Diagnostic Accuracy
5%
Moyamoya Disease
5%